Literature DB >> 8922802

Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception.

N Vogel1, M Kirisits, E Michael, H Bach, M Hostetter, K Boyer, R Simpson, E Holfels, J Hopkins, D Mack, M B Mets, C N Swisher, D Patel, N Roizen, L Stein, M Stein, S Withers, E Mui, C Egwuagu, J Remington, R Dorfman, R McLeod.   

Abstract

Congenital transmission of Toxoplasma gondii from a mother who was apparently immunologically competent and who had toxoplasmic lymphadenitis 2 months before conception is described. Since no T. gondii-specific serological data were available for this mother from the time her lymph node biopsy specimen was obtained, the specimen was studied by polymerase chain reaction (PCR) to determine whether the T. gondii B1 gene was present. The predictive diagnostic value of histologic findings previously considered to be classic signs of T. gondii lymphadenitis also was studied. This was done by correlation of serological tests diagnostic of acute acquired T. gondii infection and presence of characteristic findings in biopsy specimens from persons without known immunocompromise. Both PCR and review of the characteristic features of her lymph node biopsy specimen confirmed the diagnosis of preconceptual infection in the mother. We also discuss two other cases in which apparently immunologically competent mothers with preconceptually acquired infection transmitted this parasite to their fetuses.

Entities:  

Mesh:

Year:  1996        PMID: 8922802     DOI: 10.1093/clinids/23.5.1055

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis.

Authors:  C Chemla; I Villena; D Aubert; P Hornoy; D Dupouy; B Leroux; J P Bory; J M Pinon
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

3.  Common questions about the diagnosis and management of congenital toxoplasmosis.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-03       Impact factor: 2.253

4.  Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis.

Authors:  F Foudrinier; I Villena; R Jaussaud; D Aubert; C Chemla; F Martinot; J M Pinon
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

6.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

7.  Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.

Authors:  F Robert-Gangneux; M F Gavinet; T Ancelle; J Raymond; C Tourte-Schaefer; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.

Authors:  Pierre Flori; Laetitia Tardy; Hugues Patural; Bahrie Bellete; Marie-Noëlle Varlet; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.

Authors:  John G D'Angelo; Claudia Bordón; Gary H Posner; Robert Yolken; Lorraine Jones-Brando
Journal:  J Antimicrob Chemother       Date:  2008-11-06       Impact factor: 5.790

10.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.